Back to Gene
HAX1 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

HAX1 gene

The HAX1 gene provides instructions for making the HAX-1 protein, which plays a key role in regulating cell death and is primarily found in the mitochondria.

Normal Function

The HAX1 gene provides instructions for making a protein called HS-1-associated protein X-1 (HAX-1). This protein is involved in the regulation of apoptosis, which is the process by which cells self-destruct when they are damaged or no longer needed. Apoptosis is a common process that occurs throughout life. The HAX-1 protein is also thought to be involved in cell movement (migration). The HAX-1 protein is found primarily in the mitochondria, the energy-producing centers within cells.

Different versions of the HAX-1 protein can be produced from the HAX1 gene by a mechanism called alternative splicing. This mechanism produces different versions of the protein by cutting and rearranging the genetic instructions in different ways. The purpose of these multiple versions of the HAX-1 protein is unclear.

Health Conditions Related to Genetic Changes

Severe congenital neutropenia

At least 10 mutations in the HAX1 gene have been found to cause severe congenital neutropenia, a condition characterized by a shortage (deficiency) of neutrophils. Neutrophils are a type of white blood cell that play a role in inflammation and in fighting infection. Most of the mutations that cause severe congenital neutropenia change single protein building blocks (amino acids) in the HAX-1 protein. HAX1 gene mutations that cause severe congenital neutropenia result in the production of a nonfunctional HAX-1 protein. A lack of functional HAX-1 protein disrupts regulation of apoptosis, leading to the premature death of neutrophils. A deficiency of neutrophils results in recurrent infections, episodes of inflammation, and other immune problems in people with severe congenital neutropenia.

People with certain HAX1 gene mutations have neurological problems such as seizures and developmental delay in addition to severe congenital neutropenia. These mutations disrupt two of the alternatively spliced versions of the HAX-1 protein. The gene mutations that lead to severe congenital neutropenia alone disrupt only one version of the HAX-1 protein. It is unclear how nonfunctional HAX-1 proteins cause neurological features seen in some affected individuals.

Other Names for This Gene

  • HAX-1
  • HAX1_HUMAN
  • HCLS1-associated protein X-1
  • HCLSBP1
  • HS1 binding protein
  • HS1-associating protein X-1
  • HS1-binding protein 1
  • HS1BP1
  • HSP1BP-1

Genomic Location

The HAX1 gene is found on chromosome 1.

Frequently Asked Questions

Key symptoms include recurrent, often severe bacterial infections (especially skin, respiratory, and gastrointestinal infections), fevers that do not resolve quickly, and a low absolute neutrophil count (ANC) below 500 cells/µL on two separate tests. Newborns may also exhibit poor feeding, failure to thrive, or a history of infections in the first few weeks of life.
Initial screening involves a CBC with differential to identify neutropenia. If severe congenital neutropenia is suspected, a bone marrow aspirate may be performed to assess neutrophil precursors. Genetic testing—sequencing the HAX1 gene—is definitive; it identifies pathogenic mutations that impair HAX‑1 function, confirming the diagnosis and guiding treatment decisions.
The mainstay of therapy is granulocyte colony‑stimulating factor (G‑CSF), typically given daily or every other day to raise neutrophil counts to a safe level (ANC > 1,500 cells/µL). Treatment is usually lifelong, with dose adjustments based on neutrophil response and infection risk. Regular monitoring of blood counts and infection signs is essential.
Key strategies include: keeping the child away from crowds during outbreaks, ensuring vaccinations are up to date (except live vaccines, which may be contraindicated), practicing meticulous hand hygiene, using protective clothing in dusty or dirty environments, and having a written infection‑management plan that includes early antibiotic therapy for fevers. Parents should also educate caregivers and teachers about the child’s condition and emergency protocols.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA